Thermo Fisher Scientific Inc.
TMO
$512.69
$4.590.90%
NYSE
| 12/31/2025 | 09/27/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.83% | 2.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.83% | 2.46% | |||
| Cost of Revenue | 9.83% | 1.37% | |||
| Gross Profit | 9.82% | 4.06% | |||
| SG&A Expenses | 6.37% | -1.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.25% | 0.67% | |||
| Operating Income | 20.62% | 10.69% | |||
| Income Before Tax | 16.14% | 6.84% | |||
| Income Tax Expenses | -26.09% | 125.00% | |||
| Earnings from Continuing Operations | 21.53% | 0.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -20.00% | -150.00% | |||
| Net Income | 21.53% | -0.06% | |||
| EBIT | 20.62% | 10.69% | |||
| EBITDA | 17.73% | 7.73% | |||
| EPS Basic | 22.18% | -0.06% | |||
| Normalized Basic EPS | 20.68% | 11.29% | |||
| EPS Diluted | 22.33% | -0.18% | |||
| Normalized Diluted EPS | 20.36% | 11.29% | |||
| Average Basic Shares Outstanding | -0.53% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.26% | 0.00% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.18% | 0.01% | |||